Prevention of graft-versus-host disease

Prevention of graft-versus-host disease refers to prophylactic intervention against a major systemic, immune-mediated complication that arises following allogeneic hematopoietic cell transplantation Prophylaxis aims to avert both acute and chronic forms of the disorder, which primarily target the skin, gastrointestinal tract, liver, and other epithelial or mucosal surfaces Pathophysiologically, preventive strategies seek to inhibit donor alloreactive T-cell activation, proliferation, or traffick...

Prevention of graft-versus-host disease refers to prophylactic intervention against a major systemic, immune-mediated complication that arises following allogeneic hematopoietic cell transplantation

In this clinical state, immunocompetent donor T lymphocytes recognize host minor or major histocompatibility antigens as foreign, triggering an inflammatory cascade and cytotoxic tissue destruction Prophylaxis aims to avert both acute and chronic forms of the disorder, which primarily target the skin, gastrointestinal tract, liver, and other epithelial or mucosal surfaces

In this clinical state, immunocompetent donor T lymphocytes recognize host minor or major histocompatibility antigens as foreign, triggering an inflammatory cascade and cytotoxic tissue destruction Pathophysiologically, preventive strategies seek to inhibit donor alloreactive T-cell activation, proliferation, or trafficking while mitigating systemic inflammatory damage and preserving engraftment and beneficial graft-versus-tumor responses

Prophylaxis aims to avert both acute and chronic forms of the disorder, which primarily target the skin, gastrointestinal tract, liver, and other epithelial or mucosal surfaces

Pathophysiologically, preventive strategies seek to inhibit donor alloreactive T-cell activation, proliferation, or trafficking while mitigating systemic inflammatory damage and preserving engraftment and beneficial graft-versus-tumor responses